2018
DOI: 10.2147/tcrm.s158768
|View full text |Cite
|
Sign up to set email alerts
|

Renoprotective effect of remote ischemic postconditioning in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention

Abstract: BackgroundWhether upper arm remote ischemic postconditioning (RIPostC) exerts protection to kidney in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI) remains unknown.MethodsSixty-four patients with STEMI were randomized to PPCI + RIPostC (n=29) and PPCI (n=35) groups. RIPostC consisting of 4 cycles of 5 minutes occlusion/reperfusion by cuff inflation/deflation of the upper arm was started within 1 minute after the first balloon dilatation. P… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
11
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(11 citation statements)
references
References 34 publications
0
11
0
Order By: Relevance
“…Base on this necessity, an intervention has been described consisting of several transient non-lethal ischemia cycles called remote ischemic conditioning (RIC) (9). One of the most common approaches of RIC is the RIPC method which we used in the present study (19). Several authors in their studies showed the renoprotective of RIPC during surgeries (20).…”
Section: Discussionmentioning
confidence: 99%
“…Base on this necessity, an intervention has been described consisting of several transient non-lethal ischemia cycles called remote ischemic conditioning (RIC) (9). One of the most common approaches of RIC is the RIPC method which we used in the present study (19). Several authors in their studies showed the renoprotective of RIPC during surgeries (20).…”
Section: Discussionmentioning
confidence: 99%
“…G-CSF: granulocyte colony-stimulating factor RIC represents a highly translatable therapy for multiorgan protection against ischemia-reperfusion injury (IRI). A growing number of clinical trials have indicated that RIC exerts therapeutic effects, specifically in the heart (Cao, Zhang, Wang, Xia, & Yang, 2018;Cho et al, 2017) and brain (England et al, 2017;Pico et al, 2016). However, to date, a clear understanding of the mechanism through which RIC exerts its functional benefits remains a key hurdle in its clinical translation.…”
Section: Discussionmentioning
confidence: 99%
“…In the clinical setting, application of RIC by short-term intermittent episodes of I-R is most often applied on the upper-arm and induced by alternating inflations and deflations of a standard blood pressure cuff above systolic blood pressure. In patients with STEMI treated with PPCI, proof of concept studies have demonstrated that RIC reduces cardiac biomarker release [27,28,38] and infarct size [30], improves myocardial salvage [24,31], that is, the proportion of the ischemic myocardium at risk of infarction being salvaged by the assigned treatment [47], ST-segment resolution on electrocardiogram [23] and peripheral endothelial function [29], as well as reduce the incidence of acute kidney injury [39]. Most importantly RIC reduces cardiac mortality and rehospitalisation for heart failure [40].…”
Section: Effect Of Ric In Patients With Stemimentioning
confidence: 99%